|
IQCC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.485600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.622000E-01 |
| Normal-vs-Stage2 |
8.004000E-01 |
| Normal-vs-Stage3 |
1.668620E-01 |
| Normal-vs-Stage4 |
4.329800E-01 |
| Stage1-vs-Stage2 |
4.791400E-01 |
| Stage1-vs-Stage3 |
1.679530E-02 |
| Stage1-vs-Stage4 |
1.431840E-01 |
| Stage2-vs-Stage3 |
3.051400E-01 |
| Stage2-vs-Stage4 |
6.266400E-01 |
| Stage3-vs-Stage4 |
5.686400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.448400E-01 |
| Normal-vs-AfricanAmerican |
4.869800E-01 |
| Normal-vs-Asian |
6.192300E-02 |
| Caucasian-vs-AfricanAmerican |
1.991820E-01 |
| Caucasian-vs-Asian |
2.449500E-02 |
| AfricanAmerican-vs-Asian |
1.875420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.508400E-01 |
| Normal-vs-Female |
9.809200E-01 |
| Male-vs-Female |
5.236000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.807600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.238800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.262400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.971000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.284600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.014200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.958200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.800800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.214000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.128000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.395820E-01 |
| Normal-vs-Grade 2 |
4.858600E-01 |
| Normal-vs-Grade 3 |
3.667400E-01 |
| Normal-vs-Grade 4 |
3.993900E-02 |
| Grade 1-vs-Grade 2 |
1.934960E-01 |
| Grade 1-vs-Grade 3 |
7.950200E-02 |
| Grade 1-vs-Grade 4 |
3.370100E-02 |
| Grade 2-vs-Grade 3 |
2.218200E-02 |
| Grade 2-vs-Grade 4 |
3.836300E-04 |
| Grade 3-vs-Grade 4 |
1.085020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.439600E-01 |
| Normal-vs-ccB subtype |
2.075200E-01 |
| ccA subtype-vs-ccB subtype |
1.712460E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.847800E-01 |
| Normal-vs-N1 |
8.959800E-01 |
| N0-vs-N1 |
9.485000E-01 |
|
|
